{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:30:44Z","timestamp":1793813444405,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jhepr.2026.101965","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:52:53Z","timestamp":1784703173000},"page":"101965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics analysis identifies stellate cell-derived complement component 7 as a predictor of fibrosis and liver-related events in MASLD"],"prefix":"10.1016","volume":"8","author":[{"given":"Shohei","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1481-1029","authenticated-orcid":false,"given":"Takefumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-6819","authenticated-orcid":false,"given":"Takanobu","family":"Iwadare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Taufeeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Iwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saket","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3212-3836","authenticated-orcid":false,"given":"Naoki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.101965_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101965_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3748\/wjg.v25.i2.163","article-title":"Current status, problems, and perspectives of non-alcoholic fatty liver disease research","volume":"25","author":"Tanaka","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101965_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","article-title":"Global prevalence of advanced liver fibrosis and cirrhosis in the general population: a systematic review and meta-analysis","volume":"23","author":"Zamani","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101965_bib4","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2026.101965_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/apt.18015","article-title":"Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortality","volume":"60","author":"Tamaki","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2026.101965_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00535-024-02093-z","article-title":"Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease","volume":"59","author":"Wakabayashi","year":"2024","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101965_bib7","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.3350\/cmh.2022.0436","article-title":"Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future","volume":"29","author":"Yu","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101965_bib8","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","article-title":"Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of pathology","volume":"69","author":"Neuberger","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2026.101965_bib9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"Mozes","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2026.101965_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/hepr.13745","article-title":"2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease","volume":"52","author":"Fujimori","year":"2022","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2026.101965_bib11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3748\/wjg.v24.i13.1440","article-title":"Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis","volume":"24","author":"Kimura","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101965_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbadis.2014.12.011","article-title":"Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARalpha","volume":"1852","author":"Komatsu","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2026.101965_bib13","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s10620-012-2088-5","article-title":"Clinical characteristics of young-onset ischemic colitis","volume":"57","author":"Kimura","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2026.101965_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1329294","article-title":"Long-term pemafibrate treatment exhibits limited impact on body fat mass in patients with hypertriglyceridemia accompanying NAFLD","volume":"15","author":"Iwadare","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2026.101965_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/MEG.0000000000000913","article-title":"Association between lower air pressure and the onset of ischemic colitis: a case-control study","volume":"29","author":"Kimura","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101965_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211050436","article-title":"Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease","volume":"14","author":"Sharpton","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101965_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101965_bib18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101965_bib19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2010.04.033","article-title":"Down-regulation of SREBP-1c is associated with the development of burned-out NASH","volume":"53","author":"Nagaya","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101965_bib20","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101965_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s43856-024-00499-7","article-title":"Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease","volume":"4","author":"Iwadare","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.jhepr.2026.101965_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101965_bib23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","article-title":"Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease","volume":"145","author":"Murphy","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.101965_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.10.045","article-title":"Atlas of the plasma proteome in health and disease in 53,026 adults","volume":"188","author":"Deng","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2026.101965_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2026.101965_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhepr.2026.101965_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhepr.2026.101965_bib29","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/2047-783X-19-S1-S6","article-title":"Stellate cells are mesenchymal stem cells","volume":"19","author":"Kordes","year":"2014","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jhepr.2026.101965_bib30","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.101965_bib32","doi-asserted-by":"crossref","first-page":"D440","DOI":"10.1093\/nar\/gkm883","article-title":"The gene ontology project in 2008","volume":"36","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhepr.2026.101965_bib33","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhepr.2026.101965_bib34","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhepr.2026.101965_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/liv.15792","article-title":"Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease","volume":"44","author":"Kimura","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2026.101965_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13000-024-01537-7","article-title":"Exploring LGR5 as a prognostic marker of extrahepatic cholangiocarcinoma: insights from expression analysis and clinical correlations","volume":"19","author":"Tamada","year":"2024","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jhepr.2026.101965_bib37","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41467-022-29231-6","article-title":"Adipocyte G(q) signaling is a regulator of glucose and lipid homeostasis in mice","volume":"13","author":"Kimura","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.101965_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/liv.14776","article-title":"Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD","volume":"41","author":"Kimura","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2026.101965_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-76532-5","article-title":"Circulating thrombospondin 2 as a predictor of hepatocellular carcinoma in hepatitis B patients undergoing nucleos(t)ide analog therapy","volume":"14","author":"Okumura","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.101965_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000586","article-title":"Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction-associated steatohepatitis","volume":"8","author":"Lai","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2026.101965_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.14025","article-title":"Thrombospondin 2 as a predictive biomarker for HCC in hepatitis C patients: a longitudinal study following DAA therapy","volume":"32","author":"Iwadare","year":"2025","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhepr.2026.101965_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23357-9","article-title":"Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients","volume":"12","author":"Iwadare","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.101965_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2249.2000.01263.x","article-title":"Modulation of complement membrane attack by local C7 synthesis","volume":"121","author":"Wurzner","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2026.101965_bib44","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190395","article-title":"Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant\/advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"40","author":"Hou","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jhepr.2026.101965_bib45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/hep.30508","article-title":"The role of complement in liver injury, regeneration, and transplantation","volume":"70","author":"Thorgersen","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101965_bib46","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3350\/cmh.2024.0229","article-title":"DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Magdy","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101965_bib47","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1002\/hep4.2097","article-title":"Complement complex 1 subunit q-mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseases","volume":"6","author":"Eguchi","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2026.101965_bib49","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","volume":"61","author":"DeLeve","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101965_bib50","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2026.101965_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02918614","article-title":"Complement profile in primary biliary cirrhosis","volume":"11","author":"Schlesinger","year":"1992","journal-title":"Immunol Res"},{"key":"10.1016\/j.jhepr.2026.101965_bib52","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1186\/s40001-025-03387-5","article-title":"Proteomics identifies complement protein signatures in patients with primary biliary cholangitis","volume":"30","author":"Ma","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jhepr.2026.101965_bib53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2015.12.005","article-title":"Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1","volume":"372","author":"Seol","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhepr.2026.101965_bib54","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1186\/s12885-022-10195-1","article-title":"A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cancer"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:41:00Z","timestamp":1793810460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926002363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589555926002363"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101965","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative multi-omics analysis identifies stellate cell-derived complement component 7 as a predictor of fibrosis and liver-related events in MASLD","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101965"}}